CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +9,279 | 9,279 | ||
| 2024-03-01 | Garg Pushkal CMO & EVP Dev & Med Affairs | Grant or award | +4,751 | 13,417 | ||
| 2024-03-01 | Garg Pushkal CMO & EVP Dev & Med Affairs | Grant or award · Stock Option (right to buy) | +9,279 | 9,279 | ||
| 2024-03-01 | Poulton Jeffrey V. EVP, Chief Financial Officer | Grant or award | +7,741 | 27,219 | ||
| 2024-03-01 | Poulton Jeffrey V. EVP, Chief Financial Officer | Grant or award · Stock Option (right to buy) | +15,118 | 15,118 | ||
| 2024-03-01 | Greenstreet Yvonne Chief Executive Officer | Grant or award | +23,754 | 71,882 | ||
| 2024-03-01 | Greenstreet Yvonne Chief Executive Officer | Grant or award · Stock Option (right to buy) | +46,394 | 46,394 | ||
| 2024-02-29 | SHARP PHILLIP A Director | Exercise or conversion 10b5-1 | +30,000 | $59.25 | $1.8M | 30,000 |
| 2024-02-29 | SHARP PHILLIP A Director | Sale 10b5-1 | −13,005 | $150.60 | $2.0M | 16,995 |
| 2024-02-29 | SHARP PHILLIP A Director | Sale 10b5-1 | −13,557 | $151.43 | $2.1M | 3,438 |
| 2024-02-29 | SHARP PHILLIP A Director | Sale 10b5-1 | −915 | $152.40 | $139K | 2,523 |
| 2024-02-29 | SHARP PHILLIP A Director | Sale 10b5-1 | −1,906 | $153.62 | $293K | 617 |
| 2024-02-29 | SHARP PHILLIP A Director | Sale 10b5-1 | −101 | $154.07 | $16K | 516 |
| 2024-02-29 | SHARP PHILLIP A Director | Sale 10b5-1 | −516 | $156.54 | $81K | 0 |
| 2024-02-29 | SHARP PHILLIP A Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −30,000 | 0 | ||
| 2024-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −216 | $154.54 | $33K | 5,521 |
| 2024-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −170 | $155.45 | $26K | 5,351 |
| 2024-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −100 | $156.38 | $16K | 5,251 |
| 2024-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −14 | $157.30 | $2K | 5,237 |
| 2024-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −1 | $158.09 | $158 | 5,236 |
Page 48 of 80 · 1,590 trades